164 related articles for article (PubMed ID: 16966442)
1. Cyclooxygenase-2 expression in normal and neoplastic canine mammary cell lines.
Brunelle M; Sartin EA; Wolfe LG; Sirois J; Doré M
Vet Pathol; 2006 Sep; 43(5):656-66. PubMed ID: 16966442
[TBL] [Abstract][Full Text] [Related]
2. Expression and regulation of cyclooxygenase-2 in normal and neoplastic canine keratinocytes.
Pronovost N; Suter MM; Mueller E; Sirois J; Doré M
Vet Comp Oncol; 2004 Dec; 2(4):222-33. PubMed ID: 19379296
[TBL] [Abstract][Full Text] [Related]
3. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
[TBL] [Abstract][Full Text] [Related]
4. COX-2 expression in canine normal and neoplastic mammary gland.
Dias Pereira P; Lopes CC; Matos AJ; Santos M; Gärtner F; Medeiros R; Lopes C
J Comp Pathol; 2009 May; 140(4):247-53. PubMed ID: 19203768
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 expression is associated with histologic tumor type in canine mammary carcinoma.
Heller DA; Clifford CA; Goldschmidt MH; Holt DE; Shofer FS; Smith A; Sorenmo KU
Vet Pathol; 2005 Nov; 42(6):776-80. PubMed ID: 16301573
[TBL] [Abstract][Full Text] [Related]
6. Conjugated linoleic acid (CLA) modulates prostaglandin E2 (PGE2) signaling in canine mammary cells.
Wang LS; Huang YW; Liu S; Chang HL; Ye W; Shu S; Sugimoto Y; Funk JA; Smeaks DD; Hill LN; Lin YC
Anticancer Res; 2006; 26(2A):889-98. PubMed ID: 16619484
[TBL] [Abstract][Full Text] [Related]
7. Expression of Cox-1 and Cox-2 in canine mammary tumours.
Queiroga FL; Alves A; Pires I; Lopes C
J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
[TBL] [Abstract][Full Text] [Related]
8. Expression of cyclooxygenase-2 in neoplasms of the mammary gland in bitches.
Badowska-Kozakiewicz AM; Malicka E
Pol J Vet Sci; 2010; 13(2):337-42. PubMed ID: 20731190
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of feline COX-2 and expression in feline mammary carcinomas.
Sayasith K; Sirois J; Doré M
Vet Pathol; 2009 May; 46(3):423-9. PubMed ID: 19176489
[TBL] [Abstract][Full Text] [Related]
10. COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic molecular markers.
Millanta F; Citi S; Della Santa D; Porciani M; Poli A
Breast Cancer Res Treat; 2006 Jul; 98(1):115-20. PubMed ID: 16538539
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 expression in animal cancers.
Doré M
Vet Pathol; 2011 Jan; 48(1):254-65. PubMed ID: 20876365
[TBL] [Abstract][Full Text] [Related]
12. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer.
Clemente M; Sánchez-Archidona AR; Sardón D; Díez L; Martín-Ruiz A; Caceres S; Sassi F; Dolores Pérez-Alenza M; Illera JC; Dunner S; Peña L
Vet J; 2013 Aug; 197(2):427-32. PubMed ID: 23489848
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide induces cyclooxygenase-2 expression through nuclear factor-kappaB in human prostate cell lines Differential time-dependent responses in cancer progression.
Fernández-Martínez AB; Collado B; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
Mol Cell Endocrinol; 2007 May; 270(1-2):8-16. PubMed ID: 17434257
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 (COX-2) expression in canine intracranial meningiomas.
Rossmeisl JH; Robertson JL; Zimmerman KL; Higgins MA; Geiger DA
Vet Comp Oncol; 2009 Sep; 7(3):173-80. PubMed ID: 19691646
[TBL] [Abstract][Full Text] [Related]
15. Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer.
Mohammed SI; Khan KN; Sellers RS; Hayek MG; DeNicola DB; Wu L; Bonney PL; Knapp DW
Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):479-83. PubMed ID: 15062852
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)-independent mechanisms.
Deasy BM; O'Sullivan-Coyne G; O'Donovan TR; McKenna SL; O'Sullivan GC
Cancer Lett; 2007 Oct; 256(2):246-58. PubMed ID: 17707579
[TBL] [Abstract][Full Text] [Related]
17. cDNA microarray profiles of canine mammary tumour cell lines reveal deregulated pathways pertaining to their phenotype.
Rao NA; van Wolferen ME; van den Ham R; van Leenen D; Groot Koerkamp MJ; Holstege FC; Mol JA
Anim Genet; 2008 Aug; 39(4):333-45. PubMed ID: 18462483
[TBL] [Abstract][Full Text] [Related]
18. Cox-2 levels in canine mammary tumors, including inflammatory mammary carcinoma: clinicopathological features and prognostic significance.
Queiroga FL; Perez-Alenza MD; Silvan G; Peña L; Lopes C; Illera JC
Anticancer Res; 2005; 25(6B):4269-75. PubMed ID: 16309227
[TBL] [Abstract][Full Text] [Related]
19. Ang II and EGF synergistically induce COX-2 expression via CREB in intestinal epithelial cells.
Pham H; Chong B; Vincenti R; Slice LW
J Cell Physiol; 2008 Jan; 214(1):96-109. PubMed ID: 17559081
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin receptor expression in canine mammary tumor: an immunohistochemical study.
Sfacteria A; Mazzullo G; Bertani C; Calabrò P; De Vico G; Macrì B
Vet Pathol; 2005 Nov; 42(6):837-40. PubMed ID: 16301583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
